Financial Tearsheet

Company Overview

Recent Financial News

Date   Headline
Apr 03, 2018 Aytu BioScience to Present at The MicroCap Conference on April 10th in New York City at the Essex House
Mar 20, 2018 Aytu BioScience Presents New Research Findings for Natesto(R) at the Endocrine Society's 100th Annual Meeting
Mar 07, 2018 Aytu BioScience Receives Market Registration for the MiOXSYS® System for Male Infertility in Mexico
Mar 06, 2018 Aytu BioScience Announces Closing of $12,000,000 Public Offering
Mar 01, 2018 Aytu BioScience Announces Pricing of $12,000,000 Public Offering

IR Contacts

Hayden IR

James Carbonara
1441 Broadway
Fifth Floor
New York, NY 10018
Office: (646)-755-7412
James@haydenir.com

Stock Performance

Today's Open 0.5600
Volume 1.93 million
Day Range 0.5600 - 0.5999
52 Week Range 0.3800 - 15.8000
Bid/Ask 0.5600 / 0.5779
Bid/Ask Size 35,300 X 5,000
Previous Close 0.5600
Market Cap 17.43 million
Shares Outstanding 31.12 million
Dividend/Yield 0.0000 / 0.0000%
EPS (TTM) -12.760000
P/E Ratio (TTM) N/A

Recent XBRL Filings

Filing Date Form Type Description View
Feb 08, 2018 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Nov 09, 2017 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Oct 19, 2017 10-K/A Annual report (Amendment) htmlhtml   pdfpdf  
Oct 12, 2017 10-K/A Annual report (Amendment) htmlhtml   pdfpdf  
Aug 31, 2017 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  

Management Team

Josh Disbrow, Chairman & Chief Executive Officer

Jarrett Disbrow, Chief Operating Officer

David Green, Chief Financial Officer

Board of Directors

Josh Disbrow, Chairman & Chief Executive Officer

Gary Cantrell, Director, Chair, Compensation Committee

Carl Dockery, Director, Chair, Nominating & Governance Committee

John Donofrio, Jr., Director, Chair, Audit Committee

Michael Macaluso, Director